General averages In a clinical study, participants taking semaglutide for weight management typically lost an average of approximately 5.9% of their body weight, equivalent to roughly 67 lbs, within the first three months
Always follow the instructions on your prescription label
[1] Contact your GP or diabetes care team if you notice: Consistently elevated blood glucose readings HbA1c rising above your agreed target Unexplained weight gain Return of diabetes symptoms (increased thirst, frequent urination, fatigue) Severe and persistent abdominal pain (with or without vomiting), which could indicate pancreatitis Symptoms of gallbladder disease (pain in upper right abdomen, nausea, vomiting) Signs of dehydration (dizziness, dry mouth, reduced urination) New or worsening visual symptoms, particularly if you have diabetic retinopathy Your healthcare provider may consider dose escalation (Ozempic starts at 0.25 mg weekly for 4 weeks as an initiation dose only, then 0.5 mg, with possible increases to 1 mg and 2 mg weekly doses if needed and tolerated) or investigate other factors affecting your diabetes control
If the prior authorization is approved, the medication will be covered
Off-label uses: In some cases, it may be prescribed for weight management
Identity, purity, and stability testing are performed as part of the production process to ensure consistency across lots